HomeCompareFCAFF vs MRK

FCAFF vs MRK: Dividend Comparison 2026

FCAFF yields 72.73% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $22.7K in total portfolio value· pulled ahead in Year 8
10 years
FCAFF
FCAFF
● Live price
72.73%
Share price
$2.75
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.0K
Annual income
$12.62
Full FCAFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FCAFF vs MRK

📍 MRK pulled ahead of the other in Year 8

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFCAFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FCAFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FCAFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FCAFF
Annual income on $10K today (after 15% tax)
$6,181.82/yr
After 10yr DRIP, annual income (after tax)
$10.73/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,585.99/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FCAFF + MRK for your $10,000?

FCAFF: 50%MRK: 50%
100% MRK50/50100% FCAFF
Portfolio after 10yr
$46.3K
Annual income
$5,063.20/yr
Blended yield
10.92%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FCAFF
No analyst data
Altman Z
-0.4
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FCAFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFCAFFMRK
Forward yield72.73%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$35.0K$57.7K
Annual income after 10y$12.62$10,113.78
Total dividends collected$9.0K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FCAFF vs MRK ($10,000, DRIP)

YearFCAFF PortfolioFCAFF Income/yrMRK PortfolioMRK Income/yrGap
1$14,336$3,636.36$11,213$373.04+$3.1KFCAFF
2$17,776$2,436.09$12,667$512.06+$5.1KFCAFF
3$20,432$1,411.48$14,439$708.14+$6.0KFCAFF
4$22,620$758.11$16,640$988.16+$6.0KFCAFF
5$24,596$392.20$19,432$1,394.07+$5.2KFCAFF
6$26,517$199.28$23,057$1,992.90+$3.5KFCAFF
7$28,473$100.39$27,889$2,894.79+$584.00FCAFF
8← crossover$30,517$50.37$34,518$4,286.29$4.0KMRK
9$32,678$25.23$43,912$6,494.35$11.2KMRK
10$34,978$12.62$57,714$10,113.78$22.7KMRK

FCAFF vs MRK: Complete Analysis 2026

FCAFFStock

Firm Capital Apartment Real Estate Investment Trust operates as a multi-residential real estate investment company in the United States. It owns interest in approximately 1,846 apartment units located in Florida, Connecticut, Texas, New York, New Jersey, Georgia, and Maryland; and provides preferred capital secured by multi-family residential real estate properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Firm Capital American Realty Partners Trust and changed its name to Firm Capital Apartment Real Estate Investment Trust in September 2020. Firm Capital Apartment Real Estate Investment Trust is headquartered in Toronto, Canada.

Full FCAFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FCAFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FCAFF vs SCHDFCAFF vs JEPIFCAFF vs OFCAFF vs KOFCAFF vs MAINFCAFF vs JNJFCAFF vs ABBVFCAFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.